logo

Canadian News

Share

pharma-050917_27feb20.jpg Today's Daily Dose brings you news about Menlo's Serlopitant trial results, Novavax's update on its efforts to develop a novel vaccine against coronavirus disease COVID-19, Oramed's oral insulin trial results and Vir Biotech's entry into coronavirus vaccine development space.

The Canadian stock market ended in the red for a fourth straight session as shares tumbled on Wednesday, although the loss, despite being sharp, was relatively less pronounced than in the previous two sessions.

After a flat start and a subsequent modest uptick, the Canadian stock market briefly slipped into the red Wednesday morning, but edged higher swiftly only to falter again.

Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, has a couple of events lined up for this year.

Horizon Therapeutics plc (HZNP), which reported better-than-expected earnings and sales for the fourth quarter and full-year 2019, sees itself emerging stronger this year.

Canadian shares are likely to open on a cautious note with a negative bias Wednesday morning amid rising concerns about the economic impact of the rapidly spreading coronavirus outside China.

starbucks-feb26.jpg Starbucks is introducing plant-based meat to its menu in Canada in early March. The Seattle-based coffee chain said it will introduce a new Beyond Meat, Cheddar and Egg Sandwich to its Canadian stores on March 3, along with the launch of its new spring menu. The meatless breakfast sandwich will be part of Starbucks Canada's core menu.

CIBC (CM.TO, CM) announced appointments to the bank's Executive Committee, effective March 2, 2020. Christina Kramer has been appointed Senior Executive Vice-President, Technology, Infrastructure and Innovation. Laura Dottori-Attanasio has been appointed Senior Executive Vice-President, Personal and...

The Australian and New Zealand dollars slipped against their major counterparts on Tuesday, after U.S. health authorities warned of a wider spread of the coronavirus in the U.S. and asked its citizens to prepare for the outbreak. The U.S. Centers for Disease Control and Prevention warned on Tuesday...

nemaura-feb26.jpg Nemaura Medical Inc. (NMRD), which implemented a 1-for-10 reverse split on December 5, 2019, to regain compliance with NASDAQ, has gained more than 65 percent so far this year.

pharma-050517_25feb20.jpg Today's Daily Dose brings you news about IMV's ovarian cancer trial results, reports of Iovance considering a possible sale, Nemaura's head -to-head study with a major Glucose Monitoring System, and disappointing trial results of Vanda and Supernus.

The Canadian stock market suffered its worst single-session setback since August 2015 on Tuesday as mounting worries about the impact of the coronavirus outbreak prompted investors to go on a selling spree.

After opening on a slightly mixed note, the Canadian stock market tumbled Tuesday morning, amid continued worries about the economic impact of the coronavirus, which has spread to several other countries outside China.

Merit Medical Systems Inc. (MMSI), which has been implementing several initiatives to drive shareholder value, is confident in its future growth.

Canadian shares are likely to open on a mixed note Tuesday morning, tracking a recovery in Asian and European markets.

Follow RTT
>